PAX5 and lymphoma: Aberrant somatic point mutations may also occur in PCNS-DLBCLs involving MYC and PAX5, also known as B-cell-specific activator protein (BSAP), which then become mutated oncogenes that contribute to the pathogenesis of lymphomas [10,23].